National Bank Of Canada Bio Techne Corp Transaction History

National Bank Of Canada

$57.5 Billion
Q1 2024

A detailed history of National Bank Of Canada transactions in Bio Techne Corp stock. As of the latest transaction made, National Bank Of Canada holds 34,764 shares of TECH stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,764

Previous 36,942 5.9%

Holding current value

$2.49 Million

Previous $2.85 Million 14.14%

% of portfolio

0.0%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $143,704 - $167,902	-2,178 Reduced 5.9%	34,764 $2.45 Million
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $174,972 - $259,064	3,312 Added 9.85%	36,942 $2.85 Million
Q3 2023 Oct 10, 2023	BUY	$67.52 - $89.42 $495,529 - $656,253	7,339 Added 27.91%	33,630 $2.29 Million
Q2 2023 Jul 26, 2023	BUY	$73.76 - $85.98 $1.14 Million - $1.33 Million	15,507 Added 143.8%	26,291 $2.15 Million
Q1 2023 Apr 12, 2023	BUY	$71.62 - $86.62 $441,394 - $533,839	6,163 Added 133.37%	10,784 $800,000

Q4 2022 Jan 24, 2023	BUY	$80.67 - $352.29 $360,756 - $1.58 Million	4,472 Added 3001.34%	4,621 $0
Q3 2022 Oct 13, 2022	SELL	$282.54 - $391.85 $2.54 Million - $3.53 Million	-9,000 Reduced 98.37%	149 $42,000
Q2 2022 Jul 28, 2022	BUY	$322.67 - $449.65 $2.9 Million - $4.04 Million	8,995 Added 5840.91%	9,149 $3.17 Million
Q1 2022 May 05, 2022	SELL	$353.85 - $487.79 $1.44 Million - $1.99 Million	-4,078 Reduced 96.36%	154 $67,000
Q4 2021 Jan 24, 2022	BUY	$456.15 - $525.06 $1.93 Million - $2.22 Million	4,232 New	4,232 $2.19 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.81B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Bio Techne Corp Transaction History